These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17000697

  • 1. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, Spitz MR, Wei Q.
    Clin Cancer Res; 2006 Sep 15; 12(18):5596-602. PubMed ID: 17000697
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K, Hu Z, Wang LE, Sturgis EM, El-Naggar AK, Zhang W, Wei Q.
    Carcinogenesis; 2007 Sep 15; 28(9):2008-12. PubMed ID: 17693666
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S.
    Clin Cancer Res; 2009 Mar 01; 15(5):1794-800. PubMed ID: 19240174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, El-Naggar AK, Spitz MR, Wei Q.
    Cancer Epidemiol Biomarkers Prev; 2007 Aug 01; 16(8):1633-8. PubMed ID: 17684138
    [Abstract] [Full Text] [Related]

  • 11. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
    Zhang W, Li C, Wang J, He C.
    Hepatogastroenterology; 2012 Aug 01; 59(113):141-6. PubMed ID: 21940365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
    Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q.
    Carcinogenesis; 2007 May 01; 28(5):988-94. PubMed ID: 17118968
    [Abstract] [Full Text] [Related]

  • 14. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M, Sun T, Wang L, Yu D, Zhang X, Miao X, Liu J, Zhao D, Li H, Tan W, Lin D.
    Clin Cancer Res; 2008 May 15; 14(10):3230-6. PubMed ID: 18483392
    [Abstract] [Full Text] [Related]

  • 15. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM, Wang N, Chen ZF, Duan YN, Sun DL, Li Y.
    J Gastroenterol Hepatol; 2010 Mar 15; 25(3):555-61. PubMed ID: 20074157
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y, Miao XP, Huang MY, Deng L, Lin DX, Zeng YX, Shao JY.
    Mol Carcinog; 2010 Nov 15; 49(11):944-50. PubMed ID: 20842669
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B.
    Cancer Detect Prev; 2007 Nov 15; 31(3):225-32. PubMed ID: 17561354
    [Abstract] [Full Text] [Related]

  • 19. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P, Khantapura P.
    Oral Oncol; 2006 Mar 15; 42(3):257-67. PubMed ID: 16275157
    [Abstract] [Full Text] [Related]

  • 20. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
    Zhang Z, Xue H, Gong W, Wang M, Yuan L, Han S, Zhang Z.
    Carcinogenesis; 2009 Mar 15; 30(3):487-93. PubMed ID: 19168581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.